Our History
| 1989 | Establishment of Sun Instruments Japan Co., Ltd. Begins importation and sales of critical care products as the Japanese legal entity of Biosensors International. (BSI) |
|---|---|
| 1991 | BSI begins the manufacture and sales of critical care products, and starts expanding globally. In the same year, research and development begins in the area of cardiovascular therapy. |
| 1998 | Establishment of Biosensors International Group Ltd. (BIG) |
| 1999 | Sun Instruments Japan Co., Ltd. becomes Biosensors Japan Co., Ltd. |
| 2000 | BIG enters into the field of cardiovascular therapy. |
| 2002 | Sales begin in Japan of the Powerline™ PTCA balloon catheter. |
| 2005 | BIG is listed on the Singapore Exchange (SGX). |
| 2007 | Sales begin in Japan of the S-STENT™ coronary artery stent system. |
| 2012 | Main office is transferred to its present location in Uchisaiwaicho, Chiyoda-ku. In the same year, the company entered into the field of cardiac imaging systems. |
| 2013 | Sales begin in Japan of the D-SPECT™ cardiac imaging system and the ibp-22® PTCA balloon Catheter. |
| 2017 | Sales begin in Japan of the BioFreedom™ Drug coated stents. |
CAUTION: The law restricts these devices to sale by or on the order of a physician. Prior to use, it is important to read the "Instructions for Use" supplied with these devices for indications, contraindications, suggested procedures, warnings, and precautions.
Biosensors' interventional cardiology products, including S-Stent™, and Powerline™ are not available for sale in the United States and certain other countries. All other trademarks are the property of their respective owners.
S-Stent,and Powerline are trademarks or registered trademarks of Biosensors International Group, Ltd. in the United States and certain other countries. All cited trademarks are the property of their respective owners.
